Phibro Animal Health Corporation $PAHC Shares Purchased by LPL Financial LLC

Key Points

• LPL Financial LLC increased its stake in Phibro Animal Health Corporation by 46.8% in Q1, owning 128,335 shares worth approximately $2.74 million.
• Phibro Animal Health recently announced a quarterly dividend of $0.12, representing an annualized dividend yield of 1.6%.
• JPMorgan Chase & Co. upgraded the stock from a "neutral" to an "overweight" rating, raising the target price from $25.00 to $35.00.

LPL Financial LLC raised its position in shares of Phibro Animal Health Corporation (NASDAQ:PAHC - Free Report) by 46.8% in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 128,335 shares of the company's stock after purchasing an additional 40,889 shares during the period. LPL Financial LLC owned 0.32% of Phibro Animal Health worth $2,741,000 at the end of the most recent quarter.

A number of other institutional investors also recently made changes to their positions in the stock. Sterling Capital Management LLC lifted its stake in shares of Phibro Animal Health by 2.4% in the 4th quarter. Sterling Capital Management LLC now owns 18,762 shares of the company's stock worth $394,000 after acquiring an additional 448 shares during the period. Point72 Asia Singapore Pte. Ltd. purchased a new stake in shares of Phibro Animal Health during the 4th quarter worth about $29,000. Price T Rowe Associates Inc. MD lifted its stake in shares of Phibro Animal Health by 9.7% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 17,668 shares of the company's stock valued at $372,000 after purchasing an additional 1,565 shares during the last quarter. Lazard Asset Management LLC boosted its stake in shares of Phibro Animal Health by 2,739.7% during the 4th quarter. Lazard Asset Management LLC now owns 1,647 shares of the company's stock worth $34,000 after acquiring an additional 1,589 shares in the last quarter. Finally, Cetera Investment Advisers boosted its holdings in shares of Phibro Animal Health by 18.9% during the 1st quarter. Cetera Investment Advisers now owns 11,550 shares of the company's stock worth $247,000 after buying an additional 1,840 shares during the period. 99.34% of the stock is owned by institutional investors and hedge funds.

Phibro Animal Health Price Performance

NASDAQ:PAHC opened at $30.67 on Monday. Phibro Animal Health Corporation has a 1-year low of $16.16 and a 1-year high of $31.80. The company has a current ratio of 2.91, a quick ratio of 1.23 and a debt-to-equity ratio of 2.67. The firm has a fifty day simple moving average of $27.57 and a 200 day simple moving average of $23.80. The stock has a market capitalization of $1.24 billion, a PE ratio of 39.32, a P/E/G ratio of 0.51 and a beta of 0.80.

Phibro Animal Health Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, September 24th. Investors of record on Wednesday, September 3rd will be paid a $0.12 dividend. The ex-dividend date of this dividend is Wednesday, September 3rd. This represents a $0.48 annualized dividend and a dividend yield of 1.6%. Phibro Animal Health's dividend payout ratio (DPR) is currently 61.54%.

Analyst Upgrades and Downgrades

Several research firms recently commented on PAHC. JPMorgan Chase & Co. upgraded shares of Phibro Animal Health from a "neutral" rating to an "overweight" rating and upped their target price for the company from $25.00 to $35.00 in a research note on Monday, July 7th. Morgan Stanley set a $26.00 price objective on shares of Phibro Animal Health and gave the stock an "equal weight" rating in a report on Wednesday, June 25th. Wall Street Zen raised shares of Phibro Animal Health from a "hold" rating to a "buy" rating in a research note on Friday, May 9th. BNP Paribas upgraded shares of Phibro Animal Health to a "hold" rating in a research report on Monday, June 16th. Finally, BNP Paribas Exane upgraded shares of Phibro Animal Health from an "underperform" rating to a "neutral" rating and set a $24.00 price target on the stock in a research report on Monday, June 16th. Two analysts have rated the stock with a sell rating, three have issued a hold rating and two have assigned a buy rating to the company. According to MarketBeat, the company currently has an average rating of "Hold" and a consensus price target of $24.40.

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.